Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 77026 - 77050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tazarotene	Approved	SLC5A5	6528	upregulated	tazarotene results in increased expression of SLC5A5 mRNA	19p13.11	A20541
Telmisartan	Approved Investigational	ABCG1	9619	upregulated	telmisartan results in increased expression of ABCG1 mRNA	21q22.3	A21505
Telmisartan	Approved Investigational	CD36	948	upregulated	telmisartan results in increased expression of CD36 mRNA	7q21.11	A21505
Telmisartan	Approved Investigational	CXCL8	3576	downregulated	telmisartan metabolite results in decreased expression of CXCL8 mRNA	4q13.3	A23838
Telmisartan	Approved Investigational	TJP1	7082	downregulated	telmisartan results in decreased expression of TJP1 mRNA	15q13.1	A24398
Temozolomide	Approved Investigational	BCL2L11	10018	upregulated	temozolomide results in increased expression of BCL2L11 mRNA	2q13	A23346
Temozolomide	Approved Investigational	FASLG	356	upregulated	temozolomide results in increased expression of FASLG mRNA	1q24.3	A23346
Temozolomide	Approved Investigational	PTGS2	5743	downregulated	temozolomide results in decreased expression of PTGS2 mRNA	1q31.1	A24399
Temozolomide	Approved Investigational	SOD2	6648	downregulated	temozolomide results in decreased expression of SOD2 mRNA	6q25.3	A24399
Temozolomide	Approved Investigational	XIAP	331	downregulated	temozolomide results in decreased expression of XIAP mRNA	Xq25	A24399
Temsirolimus	Approved Investigational	BCL2	596	downregulated	temsirolimus results in decreased expression of BCL2 mRNA	18q21.33	A22649
Temsirolimus	Approved Investigational	CASP3	836	upregulated	temsirolimus results in increased expression of CASP3 mRNA	4q35.1	A22649
Temsirolimus	Approved Investigational	CDKN1A	1026	upregulated	temsirolimus results in increased expression of CDKN1A mRNA	6p21.2	A22649
Temsirolimus	Approved Investigational	DPYD	1806	downregulated	temsirolimus results in decreased expression of DPYD mRNA	1p21.3	A22649
Temsirolimus	Approved Investigational	TYMS	7298	downregulated	temsirolimus results in decreased expression of TYMS mRNA	18p11.32	A22649
Teniposide	Approved Investigational	CDKN1A	1026	upregulated	Teniposide results in increased expression of CDKN1A mRNA	6p21.2	A22586
Teniposide	Approved Investigational	CETP	1071	upregulated	Teniposide results in increased expression of CETP mRNA	16q13	A22586
Teniposide	Approved Investigational	MYC	4609	downregulated	Teniposide results in decreased expression of MYC mRNA	8q24.21	A20665
Teniposide	Approved Investigational	NR1H3	10062	upregulated	Teniposide results in increased expression of NR1H3 mRNA	11p11.2	A22586
Teniposide	Approved Investigational	NRIP1	8204	downregulated	Teniposide results in decreased expression of NRIP1 mRNA	21q11.2-q21.1	A22586
Tenofovir disoproxil	Approved Investigational	CCL20	6364	upregulated	Tenofovir results in increased expression of CCL20 mRNA	2q36.3	A24400
Tenofovir disoproxil	Approved Investigational	CXCL8	3576	upregulated	Tenofovir results in increased expression of CXCL8 mRNA	4q13.3	A24400
Tenofovir disoproxil	Approved Investigational	NT5E	4907	upregulated	Tenofovir results in increased expression of NT5E mRNA	6q14.3	A24400
Tenofovir disoproxil	Approved Investigational	NT5M	56953	downregulated	Tenofovir results in decreased expression of NT5M mRNA	17p11.2	A24400
Tenofovir disoproxil	Approved Investigational	TNF	7124	downregulated	Tenofovir results in decreased expression of TNF mRNA	6p21.33	A24400

Displaying entries 77026 - 77050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability